27506220|t|Medication, rehabilitation and health care consumption in adults with cerebral palsy: A population based study
27506220|a|To evaluate medication, rehabilitation and healthcare consumption in adults with CP as a function of Gross Motor Function Classification System (GMFCS) level. Questionnaire -based cross-sectional study. Brittany, a French county. Adults with cerebral palsy. Questionnaires relating to drugs, orthotic devices, mobility aids, rehabilitation and medical input were sent to 435 members of a unique regional French network dedicated to adults with cerebral palsy. The questionnaire was completed by the participant or a helper if necessary. Of the 282 responders, 7.8% had a GMFCS level of I, 14.2% II, 17.7% III, 29.1% IV and 31.2% V. Participants consumed a large amount of healthcare. Almost three-quarters took orally administered drugs, of which antispastic and antiepileptic drugs were among the most frequent. Nearly all patients had at least one type of rehabilitation, 87.2% had physiotherapy, 78% used at least one mobility aid and 69.5% used at least one orthotic device. The frequency of numerous inputs increased with GMFCS level. Specificities were found for each GMFCS level, e.g. participants with GMFCS level IV and V had a high level of medical input and a greater use of trunk-supporting devices, antireflux and laxative. Profiles could be established based on GMFCS levels. Adults with cerebral palsy use a large amount of drugs, mobility aids, orthotic devices, rehabilitation and medical input. Healthcare is targeted at cerebral palsy -related issues. GMFCS is a determinant of healthcare consumption and thus a useful tool for clinical practice to target care appropriately.
27506220	0	10	Medication	T058	C2081612
27506220	12	26	rehabilitation	T169	C0034992
27506220	31	54	health care consumption	T055	C0814514
27506220	58	64	adults	T100	C0001675
27506220	70	84	cerebral palsy	T047	C0007789
27506220	88	110	population based study	T062	C1709599
27506220	123	133	medication	T058	C2081612
27506220	135	149	rehabilitation	T169	C0034992
27506220	154	176	healthcare consumption	T055	C0814514
27506220	180	186	adults	T100	C0001675
27506220	192	194	CP	T047	C0007789
27506220	200	208	function	T169	C0542341
27506220	212	254	Gross Motor Function Classification System	T170	C3873236
27506220	256	261	GMFCS	T170	C3873236
27506220	270	283	Questionnaire	T170	C0034394
27506220	291	312	cross-sectional study	T062	C0010362
27506220	314	322	Brittany	T083	C0017446
27506220	326	339	French county	T083	C0079170
27506220	341	347	Adults	T100	C0001675
27506220	353	367	cerebral palsy	T047	C0007789
27506220	369	383	Questionnaires	T170	C0034394
27506220	396	401	drugs	T121	C0013227
27506220	403	419	orthotic devices	T074	C0029365
27506220	421	434	mobility aids	T074	C3495449
27506220	436	450	rehabilitation	T169	C0034992
27506220	455	468	medical input	T033	C0496675
27506220	474	478	sent	T169	C1519246
27506220	486	493	members	T098	C0680022
27506220	499	505	unique	T080	C1710548
27506220	506	521	regional French	T083	C0017446
27506220	522	529	network	T169	C1882071
27506220	543	549	adults	T100	C0001675
27506220	555	569	cerebral palsy	T047	C0007789
27506220	575	588	questionnaire	T170	C0034394
27506220	593	602	completed	T080	C0205197
27506220	610	621	participant	T098	C0679646
27506220	627	633	helper	UnknownType	C0682221
27506220	659	669	responders	T033	C0919876
27506220	682	693	GMFCS level	T170	C3873236
27506220	743	755	Participants	T098	C0679646
27506220	767	793	large amount of healthcare	T055	C0814514
27506220	795	816	Almost three-quarters	T081	C2825406
27506220	822	847	orally administered drugs	T121	C0013227
27506220	858	869	antispastic	T121	C4020576
27506220	874	893	antiepileptic drugs	T121	C0003299
27506220	909	922	most frequent	T079	C0332183
27506220	935	943	patients	T101	C0030705
27506220	969	983	rehabilitation	T169	C0034992
27506220	995	1008	physiotherapy	T061	C0949766
27506220	1032	1044	mobility aid	T074	C3495449
27506220	1073	1088	orthotic device	T074	C0029365
27506220	1094	1103	frequency	T079	C0439603
27506220	1138	1149	GMFCS level	T170	C3873236
27506220	1151	1164	Specificities	T081	C0037791
27506220	1170	1175	found	T033	C0150312
27506220	1185	1196	GMFCS level	T170	C3873236
27506220	1203	1215	participants	T098	C0679646
27506220	1221	1232	GMFCS level	T170	C3873236
27506220	1248	1258	high level	T080	C0441889
27506220	1262	1275	medical input	T033	C0496675
27506220	1282	1296	greater use of	T169	C1524063
27506220	1297	1321	trunk-supporting devices	T074	C0025080
27506220	1323	1333	antireflux	T061	C0399651
27506220	1338	1346	laxative	T121	C0282090
27506220	1348	1356	Profiles	T081	C0237801
27506220	1387	1399	GMFCS levels	T170	C3873236
27506220	1401	1407	Adults	T100	C0001675
27506220	1413	1427	cerebral palsy	T047	C0007789
27506220	1434	1446	large amount	T081	C3869890
27506220	1450	1455	drugs	T121	C0013227
27506220	1457	1470	mobility aids	T074	C3495449
27506220	1472	1488	orthotic devices	T074	C0029365
27506220	1490	1504	rehabilitation	T169	C0034992
27506220	1509	1522	medical input	T033	C0496675
27506220	1524	1534	Healthcare	T058	C0086388
27506220	1538	1546	targeted	T169	C1521840
27506220	1550	1564	cerebral palsy	T047	C0007789
27506220	1550	1580	cerebral palsy -related issues	T033	C0033213
27506220	1582	1587	GMFCS	T170	C3873236
27506220	1593	1604	determinant	T169	C1521761
27506220	1608	1630	healthcare consumption	T055	C0814514
27506220	1658	1675	clinical practice	T057	C0205897
27506220	1679	1685	target	T169	C1521840
27506220	1686	1690	care	T052	C1947933
27506220	1691	1704	appropriately	T080	C1548787